CompletedNot Applicable

Endovascular Treatment of Aorto-iliac Occlusions

Serbia100 participantsStarted 2013-01-01

Plain-language summary

This study compares early and long-term results of the endovascular treatment among patients with different types of aorto-iliac occlusions.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient has aorto-iliac occlusions type B, C \& D according to TASC-II classification * Patient suffers from severe claudication (Rutherford 3) or critical limb ischemia (Rutherford 4 and 5) * Patients fulfilling criteria for endovascular treatment of aorto-iliac occlusion according to criteria of the participating centres. Exclusion Criteria: * Patients with associated abdominal or iliac aneurysm, restenotic lesions, acute thrombi or dissections, * Patients who experienced an initial technical failure

What they're measuring

Primary artery/stent patency rate

Timeframe: 60 Months

Trial details

NCT IDNCT03824730

SponsorClinical Centre of Serbia

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2017-11-01

View on ClinicalTrials.gov More Aorto-Iliac Occlusive Disease trials